Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alan Peter Lewis is active.

Publication


Featured researches published by Alan Peter Lewis.


Microbiology | 2002

Characterization of a Mycobacterium tuberculosis H37Rv transposon library reveals insertions in 351 ORFs and mutants with altered virulence

Ruth Mcadam; Selwyn Quan; Debbie A. Smith; Stoyan Bardarov; Joanna Betts; Fiona C. Cook; Elizabeth U. Hooker; Alan Peter Lewis; Peter Woollard; Martin J. Everett; Pauline T. Lukey; Gregory J. Bancroft; William R. Jacobs; Ken Duncan

A library of Mycobacterium tuberculosis insertional mutants was generated with the transposon Tn5370. The junction sequence between the transposon and the mycobacterial chromosome was determined, revealing the positions of 1329 unique insertions, 1189 of which were located in 351 different ORFs. Transposition was not completely random and examination of the most susceptible genome regions revealed a lower-than-average G+C content ranging from 54 to 62 mol%. Mutants were obtained in all of the recognized M. tuberculosis functional protein-coding gene classes. About 30% of the disrupted ORFs had matches elsewhere in the genome that suggested redundancy of function. The effect of gene disruption on the virulence of a selected set of defined mutants was investigated in a severe combined immune deficiency (SCID) mouse model. A range of phenotypes was observed in these mutants, the most notable being the severe attenuation in virulence of a strain disrupted in the Rv1290c gene, which encodes a protein of unknown function. The library described in this study provides a resource of defined mutant strains for use in functional analyses aimed at investigating the role of particular M. tuberculosis genes in virulence and defining their potential as targets for new anti-mycobacterial drugs or as candidates for deletion in a rationally attenuated live vaccine.


Developmental and Comparative Immunology | 1993

Cloning and sequence analysis of κ and γ cynomolgus monkey immunoglobulin cDNAs

Alan Peter Lewis; Karen A. Barber; Helen Cooper; Martin J. Sims; Jenny Worden; J. Scott Crowe

Abstract One γ heavy chain and 10 κ light chain cynomolgus monkey ( Macaca fasicularis ) immunoglobulin cDNAs have been cloned and sequenced. Comparisons of the variable (V) regions to human antibody sequences have revealed extensive identity, exhibiting 93% at the amino acid level for the V H framework regions, and 88–99% for the V κ frameworks. Identification of very few cynomolgus monkey-specific framework region residues suggests a role for cynomolgus monkey antibodies as donators of variable regions to chimeric monoclonal antibodies for utilisation in human therapy with human constant (C) regions. The cynomolgus monkey C κ region exhibited 83% amino acid identity to its human counterpart, and the C γ region was 95, 93, 95, and 95% similar to the human C γ1 , C γ2 , C γ3 , and C γ4 regions, respectively. Evolutionary analysis of the C γ genes, using the silent molecular clock, suggests that the divergence between cynomolgus monkey and human occurred before the time at which the ancestral γ gene diverged into the multiple isotypes observed in humans.


Journal of Immunology | 2004

Differential Gene Expression Identifies Novel Markers of CD4+ and CD8+ T Cell Activation Following Stimulation by Mycobacterium tuberculosis

Jacqueline M. Cliff; Iryna N. J. Andrade; Rohit Mistry; Chris Clayton; Mark Lennon; Alan Peter Lewis; Ken Duncan; Pauline T. Lukey; Hazel M. Dockrell

T cell activation in response to antigenic stimulation is a complex process, involving changes in the expression level of a large number of genes. We have used cDNA array technology to characterize the differences in gene expression between human CD4+ and CD8+ T cells. PBMC from six healthy donors were stimulated with live Mycobacterium tuberculosis, and the gene expression profiles of each donor’s CD4+ and CD8+ T cells were analyzed separately. ANOVA revealed 518 genes that were consistently differentially expressed between CD4+ and CD8+ T cells. These differentially expressed genes include a combination of well-known, previously characterized genes with a range of biological functions and unknown in silico predicted hypothetical genes. Where possible, the novel genes have been characterized using bioinformatics, and putative transcription factors, signaling molecules, transmembrane, and secreted factors have been identified. A subset of these differentially expressed genes could be exploited as markers of CD4+ and CD8+ T cell activation for use in vaccine trials. These observed differences in the gene expression profile of CD4+ and CD8+ T cells following activation by a human pathogen contribute to an increased understanding of T cell activation and differentiation and the roles these T cell subsets may play in immunity to infection.


Bioinformatics | 2018

SCALOP: sequence-based antibody canonical loop structure annotation

Wing Ki Wong; Guy Georges; Francesca Ros; Sebastian Kelm; Alan Peter Lewis; Bruck Taddese; Jinwoo Leem; Charlotte M. Deane

Abstract Motivation Canonical forms of the antibody complementarity-determining regions (CDRs) were first described in 1987 and have been redefined on multiple occasions since. The canonical forms are often used to approximate the antibody binding site shape as they can be predicted from sequence. A rapid predictor would facilitate the annotation of CDR structures in the large amounts of repertoire data now becoming available from next generation sequencing experiments. Results SCALOP annotates CDR canonical forms for antibody sequences, supported by an auto-updating database to capture the latest cluster information. Its accuracy is comparable to that of a standard structural predictor but it is 800 times faster. The auto-updating nature of SCALOP ensures that it always attains the best possible coverage. Availability and implementation SCALOP is available as a web application and for download under a GPLv3 license at opig.stats.ox.ac.uk/webapps/scalop. Supplementary information Supplementary data are available at Bioinformatics online.


Archive | 2012

BCMA(CD269/TNFRSF17)-binding proteins

Paul Algate; Stephanie Jane Clegg; Jennifer L. Craigen; Paul Andrew Hamblin; Alan Peter Lewis; Patrick Mayes; Radha Shah Parmar; Trevor Anthony Kenneth Wattam


Fems Microbiology Letters | 2005

DING proteins are from Pseudomonas

Alan Peter Lewis; Daniel Crowther


Archive | 2016

MODIFIED SINGLE VARIABLE DOMAIN ANTIBODIES WITH REDUCED BINDING TO ANTI-DRUG-ANTIBODIES

Claire Ashman; Mary Birchler; Rudolf M T De Wildt; Claire Holland; Alan Peter Lewis; Peter Morley; Thomas Sandal; Michael Steward


Journal of Immunology | 1993

Rescue, expression, and analysis of a neutralizing human anti-hepatitis A virus monoclonal antibody.

Alan Peter Lewis; Stanley M. Lemon; Karen A. Barber; Paula C. Murphy; Nigel R. Parry; Tim C. Peakman; Martin J. Sims; Jenny Worden; James Scott Crowe


Archive | 2008

Il-23 antibodies

Gary Peter Bembridge; Jane Elizabeth Clarkson; Jonathan Henry Ellis; Paul Andrew Hamblin; George Kopsidas; Alan Peter Lewis; Ruth Mcadam


Archive | 2014

Anti-lag-3 binding proteins

Paul Hamblin; Alan Peter Lewis; Thomas Matthew Webb

Collaboration


Dive into the Alan Peter Lewis's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael Steward

Catholic University of Leuven

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge